Fabrication, implantation, elution, and retrieval of a steroid‐loaded polycaprolactone subretinal implant
Authors:
- Eugene de JuanEJEugene de Juan
- Signe E. VarnerSVSigne E. Varner
- 17 May 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 73A (4) , 437-444
Abstract
A subretinal drug delivery system was developed to overcome the limitations of current treatments for retinal disease. A rod‐shaped implant was made by embedding the corticosteroid triamcinolone acetonide within a biodegradable polycaprolactone polymer matrix. The implant was fabricated by homogenously mixing the polymer and drug in solvent. The mixture was then dried, melted, and extruded, and the prepared solid form was drawn into a filament. The rods were mechanically sectioned to a length of 2 mm with a diameter of up to 320 μm. The rods were successfully implanted into the subretinal space of six rabbits. No complications were observed during the 4‐week follow‐up period. Initial observations of the implantation and elution characteristics revealed that polycaprolactone is well tolerated by the retinal tissue and that the implant can elute steroid for a period of at least 4 weeks without eliciting inflammatory response or complications. In vitro drug elution rates of different polymer to drug ratios and geometries into a balanced salt solution/bovine serum albumin (1%) solution showed an early rapid‐release phase and late first‐order phase. Histology and device retrieval after implantation revealed minimal encapsulation and good preservation of cellular morphology during the follow‐up period and a more fibrous polymer microstructure of the implant. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005Keywords
This publication has 13 references indexed in Scilit:
- Safety of an Intravitreal Injection of TriamcinoloneArchives of Ophthalmology (1950), 2004
- Nebenwirkungen und Komplikationen der intravitrealen Triamcinolonacetonid-TherapieDer Ophthalmologe, 2004
- Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusionAmerican Journal of Ophthalmology, 2003
- Ocular Drug Delivery Targeting the Retina and Retinal Pigment Epithelium Using Polylactide NanoparticlesInvestigative Ophthalmology & Visual Science, 2003
- Advances in the development of visual prosthesesCurrent Opinion in Ophthalmology, 2003
- Intravitreal Triamcinolone Acetonide Inhibits Choroidal Neovascularization in a Laser-Treated Rat ModelArchives of Ophthalmology (1950), 2001
- Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine AVeterinary Ophthalmology, 2000
- THE RISKS OF SYSTEMIC CORTICOSTEROID USEDermatologic Clinics, 1998
- Intravitreal sustained-release cyclosporine in the treatment of experimental uveitisOphthalmology, 1998
- Effects of Intravitreal Administration of Steroids on Experimental Subretinal Neovascularization in the Subhuman PrimateArchives of Ophthalmology (1950), 1985